Fredun Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Fredun Pharmaceuticals has a total shareholder equity of ₹1.1B and total debt of ₹649.5M, which brings its debt-to-equity ratio to 58.3%. Its total assets and total liabilities are ₹2.8B and ₹1.7B respectively. Fredun Pharmaceuticals's EBIT is ₹333.5M making its interest coverage ratio 3.1. It has cash and short-term investments of ₹27.3M.
Key information
58.3%
Debt to equity ratio
₹649.51m
Debt
Interest coverage ratio | 3.1x |
Cash | ₹27.27m |
Equity | ₹1.11b |
Total liabilities | ₹1.67b |
Total assets | ₹2.79b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 539730's short term assets (₹2.3B) exceed its short term liabilities (₹1.5B).
Long Term Liabilities: 539730's short term assets (₹2.3B) exceed its long term liabilities (₹204.1M).
Debt to Equity History and Analysis
Debt Level: 539730's net debt to equity ratio (55.9%) is considered high.
Reducing Debt: 539730's debt to equity ratio has increased from 58% to 58.3% over the past 5 years.
Debt Coverage: 539730's debt is well covered by operating cash flow (89.4%).
Interest Coverage: 539730's interest payments on its debt are well covered by EBIT (3.1x coverage).